KRKA, d.d., Novo Mesto (primary and secondary packaging, batch control (chemical/physical and microbiological testing) and batch release) / KRKA, d.d., Novo Mesto (batch control (chemical/physical testing))
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of functional urinary tract disorders occurring in benign prostatic hyperplasia.
Dosage form: tablets, extended-release
Active substance Dosage tamsulosin 0.4 mg ATC: G04CA02